Generic Drugs
-
{
- All
- News
- Videos
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
- Friday April 17, 2026
- Health | Written by Sambhav Kumar
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
www.ndtv.com
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
- Wednesday April 15, 2026
- Health | Written by Sambhav Kumar
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
www.ndtv.com
-
From Pharmacy Of World To Innovation Hub: PM Modi Bats For India's Pharmaceutical Leap
- Tuesday April 14, 2026
- Health | Indo Asian Service News
New Delhi, April 14 (IANS) Prime Minister Narendra Modi on Tuesday said that India’s pharma sector is moving up from the pharmacy of the world to a hub of innovation.
-
www.ndtv.com
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
- Monday April 13, 2026
- Health | Indo Asian Service News
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
www.ndtv.com
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
- Wednesday April 8, 2026
- Health | Written by Shreya Goswami
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
www.ndtv.com
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
- Friday April 3, 2026
- World News | Edited by Srishti Kapoor
The bigger picture threatens a move away from established production hubs like India.
-
www.ndtv.com
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
- Monday March 30, 2026
- Health | Written by Sambhav Kumar
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
www.ndtv.com
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
- Monday March 30, 2026
- Health | Asian News International
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
www.ndtv.com
-
Breakthrough: Peptide Pills Likely To Make Daily Insulin Injections Unnecessary Soon
- Wednesday March 25, 2026
- Health | Written by Shreya Goswami
Scientists have developed a peptide-based oral insulin delivery system that could replace daily injections. The innovation helps insulin survive digestion and enter the bloodstream, offering hope for easier diabetes management.
-
www.ndtv.com
-
Affordable Weight Loss Drugs In India: How Cheap GLP-1s Will Affect Obesity Treatment
- Wednesday March 25, 2026
- Health | Written by Varsha Vats
Replacing traditional weight management methods with GLP-1 medications can be effective for some, but it's essential to approach this transition with caution.
-
www.ndtv.com
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
- Friday April 17, 2026
- Health | Written by Sambhav Kumar
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
www.ndtv.com
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
- Wednesday April 15, 2026
- Health | Written by Sambhav Kumar
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
www.ndtv.com
-
From Pharmacy Of World To Innovation Hub: PM Modi Bats For India's Pharmaceutical Leap
- Tuesday April 14, 2026
- Health | Indo Asian Service News
New Delhi, April 14 (IANS) Prime Minister Narendra Modi on Tuesday said that India’s pharma sector is moving up from the pharmacy of the world to a hub of innovation.
-
www.ndtv.com
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
- Monday April 13, 2026
- Health | Indo Asian Service News
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
www.ndtv.com
-
New Diabetes Generic Drug Gets Approval In US Market: All About Dapagliflozin
- Wednesday April 8, 2026
- Health | Written by Shreya Goswami
Zydus Lifesciences has received USFDA approval for generic dapagliflozin tablets used to treat type 2 diabetes. Here's how the drug works, its benefits, and why it is important for blood sugar control and heart health.
-
www.ndtv.com
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
- Friday April 3, 2026
- World News | Edited by Srishti Kapoor
The bigger picture threatens a move away from established production hubs like India.
-
www.ndtv.com
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
- Monday March 30, 2026
- Health | Written by Sambhav Kumar
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
www.ndtv.com
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
- Monday March 30, 2026
- Health | Asian News International
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
www.ndtv.com
-
Breakthrough: Peptide Pills Likely To Make Daily Insulin Injections Unnecessary Soon
- Wednesday March 25, 2026
- Health | Written by Shreya Goswami
Scientists have developed a peptide-based oral insulin delivery system that could replace daily injections. The innovation helps insulin survive digestion and enter the bloodstream, offering hope for easier diabetes management.
-
www.ndtv.com
-
Affordable Weight Loss Drugs In India: How Cheap GLP-1s Will Affect Obesity Treatment
- Wednesday March 25, 2026
- Health | Written by Varsha Vats
Replacing traditional weight management methods with GLP-1 medications can be effective for some, but it's essential to approach this transition with caution.
-
www.ndtv.com